|
|
Volumn 4, Issue 3, 1986, Pages 279-284
|
|
Didemnin B - The first marine compound entering clinical trials as an antineoplastic agent
a
|
|
Author keywords
didemnin B
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DIDEMNIN A;
DIDEMNIN B;
ANIMAL EXPERIMENT;
BIOLOGICAL MODEL;
CANCER CHEMOTHERAPY;
CLINICAL TRIAL;
CYTOTOXICITY;
DOG;
DOSE RESPONSE;
DRUG ADMINISTRATION;
DRUG CYTOTOXICITY;
DRUG EFFICACY;
DRUG RESPONSE;
DRUG STRUCTURE;
DRUG TOXICITY;
HERPES SIMPLEX VIRUS;
IN VITRO STUDY;
INTOXICATION;
INTRAPERITONEAL DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
METHODOLOGY;
MOUSE;
NONHUMAN;
NUCLEIC ACID SYNTHESIS;
PHARMACOKINETICS;
PRIORITY JOURNAL;
PROTEIN SYNTHESIS;
RAT;
REVIEW;
SUBCUTANEOUS DRUG ADMINISTRATION;
THERAPY;
ANIMALS;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTIVIRAL AGENTS;
CELL CYCLE;
CHEMISTRY;
DEPSIPEPTIDES;
DRUG EVALUATION;
DRUG EVALUATION, PRECLINICAL;
FEMALE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MALE;
NEOPLASMS, EXPERIMENTAL;
PEPTIDES, CYCLIC;
TUMOR STEM CELL ASSAY;
|
|
EID: 0023026034
PISSN: 01676997
EISSN: 15730646
Source Type: Journal
DOI: 10.1007/BF00179597 Document Type: Review |
|
Times cited : (89)
|
|
References (19)
|
